Loading...
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Bubendorf, L Dafni, U Schöbel, M Finn, S Tischler, V Sejda, A Marchetti, A Thunnissen, E Verbeken, E Warth, A
Bubendorf, L
Dafni, U
Schöbel, M
Finn, S
Tischler, V
Sejda, A
Marchetti, A
Thunnissen, E
Verbeken, E
Warth, A
Citations
Altmetric:
Abstract
In a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome.
Authors
Bubendorf, L
Dafni, U
Schöbel, M
Finn, S
Tischler, V
Sejda, A
Marchetti, A
Thunnissen, E
Verbeken, E
Warth, A
Sansano, I
Cheney, R
Speel, E
Nonaka, Daisuke
Monkhorst, K
Hager, H
Martorell, M
Savic, S
Kerr, K
Tan, Q
Tsourti, Z
Geiger, T
Kammler, R
Schulze, K
Das-Gupta, A
Shames, D
Peters, S
Stahel, R
Dafni, U
Schöbel, M
Finn, S
Tischler, V
Sejda, A
Marchetti, A
Thunnissen, E
Verbeken, E
Warth, A
Sansano, I
Cheney, R
Speel, E
Nonaka, Daisuke
Monkhorst, K
Hager, H
Martorell, M
Savic, S
Kerr, K
Tan, Q
Tsourti, Z
Geiger, T
Kammler, R
Schulze, K
Das-Gupta, A
Shames, D
Peters, S
Stahel, R
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Article
Citation
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. 2017, 111:143-149 Lung Cancer